Jim Simons Dr Reddys Laboratories LTD Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,929,889 shares of RDY stock, worth $139 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
1,929,889
Previous 1,860,795
3.71%
Holding current value
$139 Million
Previous $129 Million
9.33%
% of portfolio
0.22%
Previous 0.2%
Shares
22 transactions
Others Institutions Holding RDY
# of Institutions
242Shares Held
23.6MCall Options Held
25.2KPut Options Held
8.5K-
Black Rock Inc. New York, NY2.18MShares$156 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A62.16MShares$155 Million0.04% of portfolio
-
Robeco Institutional Asset Management B.V.1.97MShares$142 Million0.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.56MShares$112 Million0.02% of portfolio
-
Aikya Investment Management LTD London, X01.24MShares$89 Million33.3% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $11.9B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...